Influence of antecedent Glivec® therapy (imatinib mesylate) on allogeneic stem cell transplantation outcome in CML Ph+ and ALL Ph+ patients -: single-centre experience

被引：0
|
作者：
Holowiecki, J [1 ]
Kruzel, T [1 ]
Wojnar, J [1 ]
Krawczyk-Kulis, M [1 ]
Wylezol, I [1 ]
机构：
[1] L Warynski Silesian Med Acad, Katowice, Poland
来源：
BONE MARROW TRANSPLANTATION | 2004年 / 33卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S138 / S138
页数：1
相关论文
共 50 条
  • [21] Efficacy and safety of nilotinib in Japanese patients with imatinib-resistant or -intolerant Ph+ CML or relapsed/refractory Ph+ ALL: a 36-month analysis of a phase I and II study
    Kensuke Usuki
    Arinobu Tojo
    Yasuhiro Maeda
    Yukio Kobayashi
    Akira Matsuda
    Kazuma Ohyashiki
    Chiaki Nakaseko
    Tatsuya Kawaguchi
    Hideo Tanaka
    Koichi Miyamura
    Yasushi Miyazaki
    Shinichiro Okamoto
    Kenji Oritani
    Masaya Okada
    Noriko Usui
    Tadashi Nagai
    Taro Amagasaki
    Aira Wanajo
    Tomoki Naoe
    International Journal of Hematology, 2012, 95 : 409 - 419
  • [22] A PHASE I/II STUDY OF NILOTINIB IN JAPANESE PATIENTS WITH IMATINIB-RESISTANT OR -INTOLERANT PH+ CHRONIC MYELOGENOUS LEUKEMIA (CML) OR RELAPSED/REFRACTORY PH+ ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
    Usuki, K.
    Urabe, A.
    Tojo, A.
    Maeda, Y.
    Kobayashi, Y.
    Jinnai, I.
    Ohyashiki, K.
    Nishimura, M.
    Kawaguchi, T.
    Tanaka, H.
    Miyamura, K.
    Miyazaki, Y.
    Hughes, T.
    Branford, S.
    Okamoto, S.
    Ishikawa, J.
    Okada, M.
    Usui, N.
    Amagasaki, T.
    Natori, H.
    Naoe, T.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 433 - 434
  • [23] Glivec treatment for Ph-positive (Ph+) leukemias who relapsed before or after allogeneic stem cell transplantation (ASCT) with intensive monitoring of minimal residual disease (MRD)
    Yamada, M
    Miyamura, K
    Sasaki, O
    Kamcoka, J
    Meguro, K
    Sasaki, T
    EXPERIMENTAL HEMATOLOGY, 2002, 30 (06) : 135 - 135
  • [24] Allogeneic stem cell transplantation for JMML: single-centre experience
    Mosleh, O.
    Ayas, M.
    El-Solh, H.
    Al-Jefri, A.
    Al Seraihy, A.
    Rifai, S.
    Al-Mahr, M.
    Al-Ahmari, A.
    BONE MARROW TRANSPLANTATION, 2007, 39 : S77 - S77
  • [25] Allogeneic stem cell transplantation in myelofibrosis; a single-centre experience
    Remes, K.
    Toivari, A.
    Kauppila, M.
    Putkonen, M.
    Itala-Remes, M.
    BONE MARROW TRANSPLANTATION, 2011, 46 : S366 - S366
  • [26] Impact of MRD on clinical outcomes of unrelated hematopoietic stem cell transplantation in patients with Ph+ ALL: A retrospective nationwide study
    Hirabayashi, Shigeki
    Kondo, Tadakazu
    Nishiwaki, Satoshi
    Mizuta, Shuichi
    Doki, Noriko
    Fukuda, Takahiro
    Uchida, Naoyuki
    Ozawa, Yukiyasu
    Kanda, Yoshinobu
    Imanaka, Ryota
    Takahashi, Satoshi
    Ishikawa, Jun
    Yano, Shingo
    Nakamae, Hirohisa
    Eto, Tetsuya
    Kimura, Takafumi
    Tanaka, Junji
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kako, Shinichi
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (10) : 1606 - 1618
  • [27] Genomic CDKN2A/2B deletions in adult Ph+ ALL are adverse despite allogeneic stem cell transplantation
    Pfeifer, Heike
    Raum, Katharina
    Markovic, Sandra
    Nowak, Verena
    Fey, Stephanie
    Oblaender, Julia
    Pressler, Jovita
    Boehm, Verena
    Brueggemann, Monika
    Wunderle, Lydia
    Huettmann, Andreas
    Waesch, Ralph
    Beck, Joachim
    Stelljes, Matthias
    Viardot, Andreas
    Lang, Fabian
    Hoelzer, Dieter
    Hofmann, Wolf-Karsten
    Serve, Hubert
    Weiss, Christel
    Goekbuget, Nicola
    Ottmann, Oliver G.
    Nowak, Daniel
    BLOOD, 2018, 131 (13) : 1464 - 1475
  • [28] Lung Transplantation after Allogeneic Stem Cell Transplantation: A Single-Centre Experience
    Lunardi, F.
    Rebusso, A.
    Pezzuto, F.
    Ferrigno, P.
    Fortarezza, F.
    Comacchio, G.
    Dell'Amore, A.
    Cozzi, E.
    Loy, M.
    Rea, F.
    Calabrese, F.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2020, 39 (04): : S501 - S501
  • [29] Outcome of salvage allogeneic haematopoietic cell transplantation in patients failing primary allogeneic transplantation: a single-centre experience
    Federmann, B.
    Faul, C.
    Vogel, W.
    Kanz, L.
    Bethge, W. A.
    BONE MARROW TRANSPLANTATION, 2012, 47 : S214 - S215
  • [30] Allogeneic hematopoietic stem cell transplantation after combination therapy with imatinib and intensive chemotherapy for newly diagnosed Philadelphia chromosome positive (Ph+) acute lymphoblastic leukemia.
    Usui, N
    Yano, S
    Takahara, S
    Asai, O
    Dobashi, N
    Osawa, H
    Takei, Y
    Ogasawara, Y
    Otubo, H
    Yamaguchi, Y
    Saito, T
    Minami, J
    Kaito, K
    Kobayashi, M
    BLOOD, 2005, 106 (11) : 410B - 411B
12345